(S1 (S (NP (NP (NP (NP (NN Energy) (NN supply)) (PP (IN of) (NP (DT the) (JJ mitotic) (NN cell) (NN cycle)))) (CC and) (NP (NP (DT the) (NN Na+/H+-antiport)) (PP (IN in) (NP (NN ascites) (NNS tumors))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN activation)) (PP (IN of) (NP (NN Na+) (NN transport)))) (VP (VBZ is) (ADJP (JJ due) (PP (TO to) (NP (NP (DT the) (NN exchange)) (PP (IN of) (NP (NP (NNS protons)) (VP (VBN formed) (PP (IN via) (NP (NP (NN glucose) (NN conversion)) (PP (IN into) (NP (NN lactate))) (PP (IN for) (NP (NN Na+)))))))))) (, ,) (PP (FW i.e.)) (, ,) (PP (TO to) (NP (NP (DT the) (NN stimulation)) (PP (IN of) (NP (DT the) (NN Na+/H+-antiport)))))))) (. .)))
(S1 (S (S (NP (NP (JJ Experimental) (NNS results)) (CC and) (NP (JJ theoretical) (NNS calculations))) (VP (VBP suggest) (SBAR (IN that) (S (PP (IN in) (NP (JJ glucose-containing) (NN medium))) (NP (DT the) (NN Na+) (NN transport)) (VP (VBZ increases) (PP (IN from) (NP (QP (CD 0.75) (TO to) (CD 1.78)) (NN pmol/hour))) (PP (IN per) (NP (NN cell)))))))) (. .)))
(S1 (S (S (NP (NP (DT The) (NN permeability)) (PP (IN of) (NP (NN plasma) (NNS membranes))) (PP (IN for) (NP (NN K+)))) (VP (VBZ increases) (NP (CD 2.75) (NN fold)) (, ,) (SBAR (IN while) (S (NP (NP (DT the) (JJ passive) (NN flux)) (PP (IN of) (NP (NN Na+)))) (VP (VBZ diminishes)))))) (. .)))
(S1 (S (S (S (NP (NP (DT The) (NN intensity)) (PP (IN of) (NP (NP (CD O2) (NN adsorption)) (PP (IN by) (NP (NN ascites) (NN tumor) (NNS cells)))))) (VP (VBZ does) (RB not) (ADVP (RB practically)) (VP (VB depend) (PP (IN on) (NP (NP (DT the) (JJ monovalent) (NN cation) (NN concentration) (NN gradient)) (PP (IN between) (NP (NP (DT the) (NNS cells)) (CC and) (NP (DT the) (NN culture) (NN medium))))))))) (, ,) (IN whereas) (S (NP (NP (DT the) (NN rate)) (PP (IN of) (NP (NN glycolysis)))) (VP (VBZ decreases) (PP (ADVP (RB simultaneously)) (IN with) (NP (NP (DT the) (NN diminution)) (PP (IN of) (NP (DT the) (NN concentration) (NN gradient)))))))) (. .)))
(S1 (S (S (PP (IN In) (NP (NP (JJ synchronized) (NNS cultures)) (PP (IN at) (NP (NP (DT the) (NN beginning)) (PP (IN of) (NP (DT the) (JJ mitotic) (NN cycle))))))) (, ,) (NP (NP (DT the) (NN bulk)) (PP (IN of) (NP (NN ATP))) (VP (VBN resynthesized) (PP (IN via) (NP (NN glycolysis))))) (VP (VBZ is) (VP (VBN utilized) (PP (IN for) (NP (NP (DT the) (NN synthesis)) (PP (IN of) (NP (NNS biopolymers)))))) (, ,) (SBAR (IN whereas) (S (NP (NP (DT that)) (PP (PP (IN at) (NP (NP (DT the) (NN end)) (PP (IN of) (NP (DT the) (NN S-phase))))) (CC and) (PP (IN in) (NP (DT the) (NN G2-phase))))) (VP (VBZ is) (VP (VBN utilized) (PP (IN for) (NP (NP (NN cation) (NN transport)) (PP (IN across) (NP (NN plasma) (NNS membranes))))))))))) (. .)))
(S1 (S (S (NP (NP (QP (IN From) (CD 35) (TO to) (CD 100)) (NN %)) (PP (IN of) (NP (NP (DT the) (JJ whole) (NN amount)) (PP (IN of) (NP (NP (NN ATP)) (VP (VBN resynthesized) (PP (IN via) (NP (NNS glycolysis))))))))) (VP (VBZ is) (VP (VBN utilized) (PP (IN for) (NP (NN transport) (NNS purposes)))))) (. .)))
(S1 (S (S (NP (PRP It)) (VP (VBZ is) (VP (VBN concluded) (SBAR (IN that) (S (NP (NP (DT the) (VBN observed) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN Na+/K+) (NN ratio)) (PP (IN in) (NP (NN ascites) (NN tumor) (NNS cells)))))) (VP (VBZ is) (VP (VBN connected) (PP (IN with) (NP (NP (PRP$ their) (VBN enhanced) (NN ability)) (S (VP (TO to) (VP (VB synthesize) (NP (JJ lactic) (NN acid)))))))))))))) (. .)))
(S1 (S (S (ADVP (RB Presumably)) (, ,) (NP (NN glycolysis)) (VP (VBZ is) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (JJ regulatory) (NNS mechanisms)) (PP (IN of) (NP (NP (JJ intracellular) (NNS ratios)) (PP (IN of) (NP (JJ monovalent) (NNS cations)))))))))) (. .)))
